Indefinite Delivery Contract HQ085926DE317

The Missile Defense Agency (MDA) awarded a Multiple Award Indefinite Delivery Indefinite Quantity (IDIQ) contract to Decision Technologies, Inc., a minority-owned small disadvantaged business headquartered in Arlington, Virginia, on December 29, 2025. The contract, designated as the Scalable Homeland Innovative Enterprise Layered Defense (SHIELD) IDIQ, carries a $151 billion ceiling value with a 10-year period of performance extending through December 28, 2035. This full and open competition vehicle with no set-aside designations was established to enable the MDA and other Department of Defense entities to rapidly procure advanced, multi-domain defense systems and capabilities. Decision Technologies, which maintains a substantial track record in defense contracting with approximately $247.2 million in prime contract awards and specializes in professional engineering support services, technical consulting, and integrated logistics support, competed successfully for inclusion on this enterprise-wide contracting mechanism.

The SHIELD IDIQ procurement supports national defense objectives through the development, integration, production, and modernization of layered defense systems capable of detecting, tracking, intercepting, and neutralizing air, missile, space, cyber, and hybrid threats across all phases of flight from ballistic, hypersonic, and cruise missiles. The initial delivery order awarded to Decision Technologies on December 29, 2025, valued at $500 under firm fixed price terms with performance in Huntsville, Alabama, represents the commencement of work under this vehicle. The contract encompasses research and development, prototyping, systems engineering, weapon design, test and evaluation, cybersecurity modernization, and related efforts structured to support both classified and unclassified programs across multiple security domains, utilizing advanced technologies including artificial intelligence, machine learning, digital engineering, and open systems architectures.